Mele, Deanna A; Sampson, James F; Huber, Brigitte T (2011) Th17 differentiation is the default program for DPP2-deficient T-cell differentiation. Eur J Immunol 41:1583-93
|
Danilov, Alexey V; Danilova, Olga V; Brown, Jennifer R et al. (2010) Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia. Exp Hematol 38:1167-77
|
Mele, Deanna A; Bista, Pradeep; Baez, Diana Velez et al. (2009) Dipeptidyl peptidase 2 is an essential survival factor in the regulation of cell quiescence. Cell Cycle 8:2425-34
|
Rockwell, Karen R; Huber, Brigitte T (2009) Biologically distinct conformations of Bcl-x can be resolved using 2D isoelectric focusing. Mol Immunol 46:1605-12
|
Danilova, Olga V; Tai, Albert K; Mele, Deanna A et al. (2009) Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance, insulin resistance, and visceral obesity. Endocrinology 150:5240-8
|
Bista, Pradeep; Mele, Deanna A; Baez, Diana Velez et al. (2008) Lymphocyte quiescence factor Dpp2 is transcriptionally activated by KLF2 and TOB1. Mol Immunol 45:3618-23
|
Danilova, Olga; Li, Bei; Szardenings, A Katrin et al. (2007) Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitor. Bioorg Med Chem Lett 17:507-10
|
Danilov, Alexey V; Klein, Andreas K; Lee, Henry J et al. (2005) Differential control of G0 programme in chronic lymphocytic leukaemia: a novel prognostic factor. Br J Haematol 128:472-81
|
Denis, Maria C; Huber, Brigitte T (2003) Native and recombinant interleukin-2, two functionally distinct molecules. Mol Immunol 40:279-86
|
Seward, Robert J; von Haller, Priska D; Aebersold, Ruedi et al. (2003) Phosphorylation of the pro-apoptotic protein Bim in lymphocytes is associated with protection from apoptosis. Mol Immunol 39:983-93
|
Showing the most recent 10 out of 15 publications